Unlike
conventional αβ T cells, γδ T cells do not rely on MHC to mediate antigen
recognition, and thus have great potential for application in cancer
immunotherapy. The article summarizes the major subpopulations of γδ T cells
and their roles in the tumor microenvironment, and analyzes current
immunotherapy strategies. Finally, it points out the challenges to be
considered in clinical applications and future research directions, which
provide new ideas for immunotherapy of oral squamous carcinoma and other
tumors.